Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registrie
about
Study of Short and Intermediate Term Clinical Outcomes of Patients with Protected and Unprotected LMCA Stenting.Efficacy of sirolimus-eluting stents compared with paclitaxel-eluting stents in an unselected population with coronary artery disease: 24-month outcomes of patients in a prospective non-randomized registry in Southern Turkey.Percutaneous coronary intervention for unprotected left main coronary artery stenosisEvaluation of Percutaneous Coronary Intervention and stenting of Left Main Coronary Artery Stenosis in Tehran's Rajaie and Lavasani Hospitals from 2010 to 2011Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis.Korean guidelines for the appropriate use of cardiac CTUtilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease.Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery diseaseSirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher RegistryPercutaneous coronary artery stenting of unprotected left main coronary artery disease using drug-eluting stents: the initial Baylor University Medical Center experienceClinical comparison of percutaneous coronary intervention with domestic drug-eluting stents versus off pump coronary artery bypass grafting in unprotected left main coronary artery diseaseTreatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?Update on drug-eluting coronary stents.Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.Optical coherence tomography for imaging the vulnerable plaque.Restenosis related to percutaneous coronary intervention has been solved?A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.Coronary artery restenosis: vascular biology and emerging therapeutic strategies.Cypher versus Taxus: the stent war.Complex coronary interventions: unprotected left main and bifurcation lesions.Percutaneous Coronary Intervention for Left Main Coronary Artery Disease - A Single Hospital Experience without On-Site Cardiac Surgery.Percutaneous coronary intervention for left main coronary artery disease.The life and hard times of a coronary surgeonComparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease.Coronary artery bypass grafting versus percutaneous intervention in heart failure.Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment.Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock.Drug-eluting stents for left main coronary artery stenosis: case selection and technical issues.Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.Off-label use of stents: bare-metal versus drug-eluting stents.Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease.Stenting versus bypass surgery for the treatment of left main coronary artery disease.Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology.Current management of left main coronary artery disease.Unprotected left main coronary stenting as alternative therapy to coronary bypass surgery in high surgical risk acute coronary syndrome patients.Drug-eluting stents in unprotected left main coronary artery disease.Stenting versus surgery for significant left main disease.Clinical implications of blood-material interaction and drug eluting stent polymers in review.
P2860
Q33741750-1D986347-C81C-49E2-8F51-0AA92AB29C12Q33949407-DE903131-1388-4378-A02C-90AE85BE3CA8Q34389836-AA686DA9-ED16-46DA-9322-CE4194F45DDEQ34621146-D3DAD6F4-31E5-4883-B544-7E7FB7DBA16DQ34773417-AB62B9EA-128A-4102-9EDE-D30977AB5971Q35140162-9267FDAA-7FAD-4ABC-BBD5-361F4CA09010Q35186556-4086218C-1092-467C-BB14-6AF6CFAA4A92Q35648305-59909D79-E16C-4188-A702-68E1BE52AFD8Q36025686-B7F075C6-B715-41F9-A48D-DAF1B4778ED7Q36054768-DA3E939E-E18F-44FC-B430-00A570DD2BCEQ36183646-35A0ED9B-69A9-41F0-B95B-4820868B655DQ36239509-9005150F-729D-4D1F-ACF0-1A5F1465D903Q36266053-5D428E19-95C3-4E6A-96D4-A0DCDD79E423Q36335174-E1E16C41-1C63-4FD2-AE60-E73FB1AE20F3Q36468238-D8E62165-4204-4534-9911-92707D492DB3Q36486769-B818B1D6-13DA-4969-A706-F6CACB54FA6EQ36488244-4B30F559-858E-4491-8F52-F696D74ACDF4Q36569798-B4A8C4E4-3F85-4197-92B3-939109DD6A18Q36654328-20324978-A3D0-437B-89C7-C9A915CA5A11Q36654384-CA70E139-4CD3-42C8-8B1F-F53C583421C5Q36721614-51DE14B4-1BEB-4B49-B52A-A0EBB3E4D108Q36752079-99489D1D-8B23-4F65-ABC4-AD75FEC36AAEQ36755375-EFC3227C-6DC2-404E-B8B8-5E283F6EC1CFQ36804733-B5F3313C-726D-400A-AD0F-8A362F036E80Q36902528-9285B015-28D0-4AFE-8D4D-5B9948713799Q36940822-73749E88-848A-4A70-B880-57C3E8DB55E4Q37049042-06DF0F24-F18C-4CC3-A3E0-19DA05258817Q37078803-650800BF-A094-47BB-9091-E9E7AFC55C69Q37188126-2E3918E6-4BCE-40F9-A986-92CD508D7F5AQ37269384-44B60273-6B41-4D31-B389-71DD33172799Q37269388-973CAD6B-D986-416A-9B59-AD460A678092Q37461045-E2DE7C72-62CE-4ECE-B8B0-472160EA188DQ37641238-08738191-3501-4F39-ADC4-F97A385849D4Q37666555-49ECC5D4-DFC3-4C93-8261-C4FCBB893836Q37909255-7BDB5E2E-62B8-44E2-BABF-3B4B3DAFC7D9Q37972593-CBE55C8C-9FF8-4821-B604-C1B2C01C9D4CQ38118220-E82D0F51-55EB-454D-A7EC-23A22DD3252DQ38262150-D67E3E5A-E972-4293-8EE4-DE5A281388DAQ38363598-D0B55014-42B1-4B51-8A79-B642EB9779BFQ38645043-BF9EB082-925E-459C-9151-4190F87A26CD
P2860
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registrie
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Short- and long-term clinical ...... Cardiology Hospital registrie
@en
Short- and long-term clinical ...... Cardiology Hospital registrie
@nl
type
label
Short- and long-term clinical ...... Cardiology Hospital registrie
@en
Short- and long-term clinical ...... Cardiology Hospital registrie
@nl
prefLabel
Short- and long-term clinical ...... Cardiology Hospital registrie
@en
Short- and long-term clinical ...... Cardiology Hospital registrie
@nl
P2093
P1433
P1476
Short- and long-term clinical ...... Cardiology Hospital registrie
@en
P2093
Andrew T L Ong
Arie Pieter Kappetein
Carlos A G van Mieghem
Eugene P McFadden
Evelyn Regar
Gaston A Rodriguez Granillo
George Sianos
Marco Valgimigli
Peter de Jaegere
P304
P356
10.1161/01.CIR.0000158486.20865.8B
P407
P577
2005-03-01T00:00:00Z